Obesity significantly contributes to both the onset and progression of T2DM through mechanisms such as enhanced genetic and epigenetic susceptibility, microenvironmental changes that impair insulin signaling, β-cell dysfunction, and alterations in the microbiome–gut–brain axis. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.